Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SEKI, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 42%
7857 SEKI CO.,LTD. 【J-GAAP】
Earnings ReportSEKI CO.,LTD. <7857> [TSE Std] announced its financial results after the market closed on February 6th (15:30). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending March 2026 (April to December) turned into a loss of 24 million yen (compared to a profit of 246 million yen in the same period last year).
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to expand 58.3% from the same period last year, reaching 326 million yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit dropped to 73 million yen, a 41.6% decrease compared to the same period last year. The operating profit/loss margin worsened from 1.7% in the same period last year to -0.3%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 8,659 | 63 | 223 | 158 | 38.1 | 46.7 | Feb 1, 2024 | J-GAAP |
| Apr - Dec, 2024 | 9,031 | 49 | 246 | 155 | 37.4 | 54.4 | Feb 7, 2025 | J-GAAP |
| Apr - Dec, 2025 | 8,724 | -204 | -24 | -22 | -5.4 | ー | Feb 6, 2026 | J-GAAP |
| YoY | -3.4% | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 6,496 | 229 | 331 | 207 | 49.8 | 13 | May 15, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 7,121 | 310 | 399 | 321 | 77.1 | 13 | Nov 6, 2025 | J-GAAP |
| YoY | +9.6% | +35.4% | +20.5% | +55.1% | +54.9% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 11,988 | 259 | 478 | 365 | 87.7 | 26 | May 16, 2024 | J-GAAP |
| Mar, 2025 | 12,302 | 224 | 452 | 280 | 67.3 | 25 | May 15, 2025 | J-GAAP |
| Mar, 2026 Guidance | 12,767 | 114 | 302 | 227 | 54.5 | 26 | May 15, 2025 | J-GAAP |
| YoY | +3.8% | -49.1% | -33.2% | -18.9% | -19.0% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 3,225 | 54 | 125 | 82 | 19.8 | 1.7 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 3,271 | 175 | 206 | 125 | 30.1 | 5.4 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 2,804 | -85 | -21 | -30 | -7.4 | -3.0 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,842 | -111 | -76 | -64 | -15.5 | -3.9 | Nov 6, 2025 | J-GAAP |
| Oct - Dec, 2025 | 3,078 | -8 | 73 | 72 | 17.7 | -0.3 | Feb 6, 2026 | J-GAAP |
| YoY | -4.6% | - | -41.6% | -12.2% | -10.8% |
Related Articles
IDEC, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.1 times, Oct-Dec Ordinary Profit Increases by 2.2 times
J-OIL MILLS, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 52%, Oct-Dec Ordinary Profit Decreases by 55%
NICHICON, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 13%
TAKAMISAWA, First Half Ordinary Profit Decreases by 28%, Oct-Dec Ordinary Profit Decreases by 17%
SAPPORO CLINICAL LAB, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Decreases by 9%
CL Holdings, Net Income Forecast for Last Fiscal Year Revised Upward by 12%, Dividend Revised Upward by 2 Yen
MT GENEX, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%, Oct-Dec Ordinary Profit Increases by 93%
Paraca, Oct-Dec (1Q) Ordinary Profit Decreases by 1%
CMK, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%
KAKEN PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 96%, Oct-Dec Ordinary Profit Decreases by 91%